Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Open access
Murray, Christopher J L, Ikuta, Kevin Shunji, Sharara, Fablina, Swetschinski, Lucien, Robles Aguilar, Gisela, Gray, Authia, Han, Chieh, Bisignano, Catherine, Rao, Puja, Wool, Eve, Johnson, Sarah C, Browne, Annie J, Chipeta, Michael Give, Fell, Frederick, Hackett, Sean, Haines-Woodhouse, Georgina, Kashef Hamadani, Bahar H, Kumaran, Emmanuelle A P, McManigal, Barney, Achalapong, Sureeruk, Agarwal, Ramesh, Akech, Samuel, Albertson, Samuel, Amuasi, John, Andrews, Jason, Aravkin, Aleskandr, Ashley, Elizabeth, Babin, François-Xavier, Bailey, Freddie, Baker, Stephen, Basnyat, Buddha, Bekker, Adrie, Bender, Rose, Berkley, James A, Bethou, Adhisivam, Bielicki, Julia, Boonkasidecha, Suppawat, Bukosia, James, Carvalheiro, Cristina, Castañeda-Orjuela, Carlos, Chansamouth, Vilada, Chaurasia, Suman, Chiurchiù, Sara, Chowdhury, Fazle, Clotaire Donatien, Rafai, Cook, Aislinn J, Cooper, Ben, Cressey, Tim R, Criollo-Mora, Elia, Cunningham, Matthew, Darboe, Saffiatou, Day, Nicholas P J, De Luca, Maia, Dokova, Klara, Dramowski, Angela, Dunachie, Susanna J, Duong Bich, Thuy, Eckmanns, Tim, Eibach, Daniel, Emami, Amir, Feasey, Nicholas, Fisher-Pearson, Natasha, Forrest, Karen, Garcia, Coralith, Garrett, Denise, Gastmeier, Petra, Giref, Ababi Zergaw, Greer, Rachel Claire, Gupta, Vikas, Haller, Sebastian, Haselbeck, Andrea, Hay, Simon I, Holm, Marianne, Hopkins, Susan, Hsia, Yingfen, Iregbu, Kenneth C, Jacobs, Jan, Jarovsky, Daniel, Javanmardi, Fatemeh, Jenney, Adam W J, Khorana, Meera, Khusuwan, Suwimon, Kissoon, Niranjan, Kobeissi, Elsa, Kostyanev, Tomislav, Krapp, Fiorella, Krumkamp, Ralf, Kumar, Ajay, Kyu, Hmwe Hmwe, Lim, Cherry, Lim, Kruy, Limmathurotsakul, Direk, Loftus, Michael James, Lunn, Miles, Ma, Jianing, Manoharan, Anand, Marks, Florian, May, Jürgen, Mayxay, Mayfong, Mturi, Neema, Munera-Huertas, Tatiana, Musicha, Patrick, Musila, Lilian A, Mussi-Pinhata, Marisa Marcia, Naidu, Ravi Narayan, Nakamura, Tomoka, Nanavati, Ruchi, Nangia, Sushma, Newton, Paul, Ngoun, Chanpheaktra, Novotney, Amanda, Nwakanma, Davis, Obiero, Christina W, Ochoa, Theresa J, Olivas-Martinez, Antonio, Olliaro, Piero, Ooko, Ednah, Ortiz-Brizuela, Edgar, Ounchanum, Pradthana, Pak, Gideok D, Paredes, Jose Luis, Peleg, Anton Yariv, Perrone, Carlo, Phe, Thong, Phommasone, Koukeo, Plakkal, Nishad, Ponce-de-Leon, Alfredo, Raad, Mathieu, Ramdin, Tanusha, Rattanavong, Sayaphet, Riddell, Amy, Roberts, Tamalee, Robotham, Julie Victoria, Roca, Anna, Rosenthal, Victor Daniel, Rudd, Kristina E, Russell, Neal, Sader, Helio S, Saengchan, Weerawut, Schnall, Jesse, Scott, John Anthony Gerard, Seekaew, Samroeng, Sharland, Mike, Shivamallappa, Madhusudhan, Sifuentes-Osornio, Jose, Simpson, Andrew J, Steenkeste, Nicolas, Stewardson, Andrew James, Stoeva, Temenuga, Tasak, Nidanuch, Thaiprakong, Areerat, Thwaites, Guy, Tigoi, Caroline, Turner, Claudia, Turner, Paul, van Doorn, H Rogier, Velaphi, Sithembiso, Vongpradith, Avina, Vongsouvath, Manivanh, Vu, Huong, Walsh, Timothy, Walson, Judd L, Waner, Seymour, Wangrangsimakul, Tri, Wannapinij, Prapass, Wozniak, Teresa, Young Sharma, Tracey E M W, Yu, Kalvin C, Zheng, Peng, Sartorius, Benn, Lopez, Alan D, Stergachis, Andy, Moore, Catrin, Dolecek, Christiane, Naghavi, Mohsen · 2022 · The Lancet

Abstract

BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 23 pathogens and 88 pathogen-drug combinations in 204 countries and territories in 2019. We obtained data from systematic literature reviews, hospital systems, surveillance systems, and other sources, covering 471 million individual records or isolates and 7585 study-location-years. We used predictive statistical modelling to produce estimates of AMR burden for all locations, including for locations with no data. Our approach can be divided into five broad components: number of deaths where infection played a role, proportion of infectious deaths attributable to a given infectious syndrome, proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antibiotic of interest, and the excess risk of death or duration of an infection associated with this resistance. Using these components, we estimated disease burden based on two counterfactuals: deaths attributable to AMR (based on an alternative scenario in which all drug-resistant infections were replaced by drug-susceptible infections), and deaths associated with AMR (based on an alternative scenario in which all drug-resistant infections were replaced by no infection). We generated 95% uncertainty intervals (UIs) for final estimates as the 25th and 975th ordered values across 1000 posterior draws, and models were cross-validated for out-of-sample predictive validity. We present final estimates aggregated to the global and regional level. FINDINGS: On the basis of our predictive statistical models, there were an estimated 4·95 million (3·62-6·57) deaths associated with bacterial AMR in 2019, including 1·27 million (95% UI 0·911-1·71) deaths attributable to bacterial AMR. At the regional level, we estimated the all-age death rate attributable to resistance to be highest in western sub-Saharan Africa, at 27·3 deaths per 100 000 (20·9-35·3), and lowest in Australasia, at 6·5 deaths (4·3-9·4) per 100 000. Lower respiratory infections accounted for more than 1·5 million deaths associated with resistance in 2019, making it the most burdensome infectious syndrome. The six leading pathogens for deaths associated with resistance (Escherichia coli, followed by Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) were responsible for 929 000 (660 000-1 270 000) deaths attributable to AMR and 3·57 million (2·62-4·78) deaths associated with AMR in 2019. One pathogen-drug combination, meticillin-resistant S aureus, caused more than 100 000 deaths attributable to AMR in 2019, while six more each caused 50 000-100 000 deaths: multidrug-resistant excluding extensively drug-resistant tuberculosis, third-generation cephalosporin-resistant E coli, carbapenem-resistant A baumannii, fluoroquinolone-resistant E coli, carbapenem-resistant K pneumoniae, and third-generation cephalosporin-resistant K pneumoniae. INTERPRETATION: To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data. AMR is a leading cause of death around the world, with the highest burdens in low-resource settings. Understanding the burden of AMR and the leading pathogen-drug combinations contributing to it is crucial to making informed and location-specific policy decisions, particularly about infection prevention and control programmes, access to essential antibiotics, and research and development of new vaccines and antibiotics. There are serious data gaps in many low-income settings, emphasising the need to expand microbiology laboratory capacity and data collection systems to improve our understanding of this important human health threat. FUNDING: Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(21)02724-0

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1: Data inputs by source type Total sample size for each source type, regardless of specific inclusion criteria for a given estimation step. Individual isolates that were tested multiple times for resistance to different antibiotics are listed only once here whenever isolates were identified uniquely in the data. For datasets where isolates could not be uniquely identified across pathogen–drug combinations, such as some antimicrobial resistance surveillance systems, some isolates might be double counted. Yellow boxes indicate that the source type was used in that estimation step. A full list of data sources included in this study, organised by data type, is included in the appendix (pp 8–15).
Figure 1: Data inputs by source type Total sample size for each source type, regardless of specific inclusion criteria for a given estimation step. Individual isolates that were tested multiple times for resistance to different antibiotics are listed only once here whenever isolates were identified uniquely in the data. For datasets where isolates could not be uniquely identified across pathogen–drug combinations, such as some antimicrobial resistance surveillance systems, some isolates might be double counted. Yellow boxes indicate that the source type was used in that estimation step. A full list of data sources included in this study, organised by data type, is included in the appendix (pp 8–15).CC BY · PubMed Central
Figure 2: All-age rate of deaths attributable to and associated with bacterial antimicrobial resistance by GBD region, 2019 Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Error bars show 95% uncertainty intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
Figure 2: All-age rate of deaths attributable to and associated with bacterial antimicrobial resistance by GBD region, 2019 Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Error bars show 95% uncertainty intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.CC BY · PubMed Central
Figure 3: Global deaths (counts) attributable to and associated with bacterial antimicrobial resistance by infectious syndrome, 2019 Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Error bars show 95% uncertainty intervals. Does not include gonorrhoea and chlamydia because we did not estimate the fatal burden of this infectious syndrome. Bone+=infections of bones, joints, and related organs. BSI=bloodstream infections. Cardiac=endocarditis and other cardiac infections. CNS=meningitis and other bacterial CNS infections. Intra-abdominal=peritoneal and intra-abdominal infections. LRI+=lower respiratory infections and all related infections in the thorax. Skin=bacterial infections of the skin and subcutaneous systems. TF–PF–iNTS= typhoid fever, paratyphoid fever, and invasive non-typhoidal Salmonella spp. UTI=urinary tract infections and pyelonephritis.
Figure 3: Global deaths (counts) attributable to and associated with bacterial antimicrobial resistance by infectious syndrome, 2019 Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Error bars show 95% uncertainty intervals. Does not include gonorrhoea and chlamydia because we did not estimate the fatal burden of this infectious syndrome. Bone+=infections of bones, joints, and related organs. BSI=bloodstream infections. Cardiac=endocarditis and other cardiac infections. CNS=meningitis and other bacterial CNS infections. Intra-abdominal=peritoneal and intra-abdominal infections. LRI+=lower respiratory infections and all related infections in the thorax. Skin=bacterial infections of the skin and subcutaneous systems. TF–PF–iNTS= typhoid fever, paratyphoid fever, and invasive non-typhoidal Salmonella spp. UTI=urinary tract infections and pyelonephritis.CC BY · PubMed Central
Figure 4: Global deaths (counts) attributable to and associated with bacterial antimicrobial resistance by pathogen, 2019 Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Error bars show 95% uncertainty intervals.
Figure 4: Global deaths (counts) attributable to and associated with bacterial antimicrobial resistance by pathogen, 2019 Estimates were aggregated across drugs, accounting for the co-occurrence of resistance to multiple drugs. Error bars show 95% uncertainty intervals.CC BY · PubMed Central
Figure 5: Pathogen-attributable fraction of deaths attributable to (A) and associated with (B) bacterial AMR for the six leading pathogens by GBD super-region, 2019 Error bars show 95% uncertainty intervals. AMR=antimicrobial resistance. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
Figure 5: Pathogen-attributable fraction of deaths attributable to (A) and associated with (B) bacterial AMR for the six leading pathogens by GBD super-region, 2019 Error bars show 95% uncertainty intervals. AMR=antimicrobial resistance. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.CC BY · PubMed Central
Figure 6: Global deaths (counts) attributable to bacterial antimicrobial resistance by pathogen–drug combination, 2019 For this figure, only deaths attributable to resistance, not deaths associated with resistance, are shown due to the very high levels of correlation for resistance patterns between some drugs. 3GC=third-generation cephalosporins. 4GC=fourth-generation cephalosporins. Anti-pseudomonal=anti-pseudomonal penicillin or beta-lactamase inhibitors. BL-BLI=β-lactam or β-lactamase inhibitors. MDR=multidrug resistance. Mono INH=isoniazid mono-resistance. Mono RIF=rifampicin mono-resistance. NA=not applicable. Resistance to 1+=resistance to one or more drug. S Paratyphi=Salmonella enterica serotype Paratyphi. S Typhi=S enterica serotype Typhi. TMP-SMX=trimethoprim-sulfamethoxazole. XDR=extensive drug resistance.
Figure 6: Global deaths (counts) attributable to bacterial antimicrobial resistance by pathogen–drug combination, 2019 For this figure, only deaths attributable to resistance, not deaths associated with resistance, are shown due to the very high levels of correlation for resistance patterns between some drugs. 3GC=third-generation cephalosporins. 4GC=fourth-generation cephalosporins. Anti-pseudomonal=anti-pseudomonal penicillin or beta-lactamase inhibitors. BL-BLI=β-lactam or β-lactamase inhibitors. MDR=multidrug resistance. Mono INH=isoniazid mono-resistance. Mono RIF=rifampicin mono-resistance. NA=not applicable. Resistance to 1+=resistance to one or more drug. S Paratyphi=Salmonella enterica serotype Paratyphi. S Typhi=S enterica serotype Typhi. TMP-SMX=trimethoprim-sulfamethoxazole. XDR=extensive drug resistance.CC BY · PubMed Central
Figure 7: Raw data and modelled estimates for the percentage of pathogen isolates that are resistant by country and territory, 2019 Meticillin-resistant Staphylococcus aureus (A), isoniazid and rifampicin co-resistant (excluding XDR) Mycobacterium tuberculosis (B), third-generation cephalosporin-resistant Escherichia coli (C), carbapenem-resistant Acinetobacter baumannii (D), fluoroquinolone-resistant E coli (E), carbapenem-resistant Klebsiella pneumoniae (F), and third-generation cephalosporin-resistant K pneumoniae (G). Locations with no data or modelled estimates are presented in white. XDR=extensively drug resistant.
Figure 7: Raw data and modelled estimates for the percentage of pathogen isolates that are resistant by country and territory, 2019 Meticillin-resistant Staphylococcus aureus (A), isoniazid and rifampicin co-resistant (excluding XDR) Mycobacterium tuberculosis (B), third-generation cephalosporin-resistant Escherichia coli (C), carbapenem-resistant Acinetobacter baumannii (D), fluoroquinolone-resistant E coli (E), carbapenem-resistant Klebsiella pneumoniae (F), and third-generation cephalosporin-resistant K pneumoniae (G). Locations with no data or modelled estimates are presented in white. XDR=extensively drug resistant.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

12 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 16,316

Metadata

Authors
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., Achalapong, S., Agarwal, R., Akech, S., Albertson, S., Amuasi, J., Andrews, J., Aravkin, A., Ashley, E., Babin, F.-X., Bailey, F., Baker, S., Basnyat, B., Bekker, A., Bender, R., Berkley, J. A., Bethou, A., Bielicki, J., Boonkasidecha, S., Bukosia, J., Carvalheiro, C., Castañeda-Orjuela, C., Chansamouth, V., Chaurasia, S., Chiurchiù, S., Chowdhury, F., Clotaire Donatien, R., Cook, A. J., Cooper, B., Cressey, T. R., Criollo-Mora, E., Cunningham, M., Darboe, S., Day, N. P. J., De Luca, M., Dokova, K., Dramowski, A., Dunachie, S. J., Duong Bich, T., Eckmanns, T., Eibach, D., Emami, A., Feasey, N., Fisher-Pearson, N., Forrest, K., Garcia, C., Garrett, D., Gastmeier, P., Giref, A. Z., Greer, R. C., Gupta, V., Haller, S., Haselbeck, A., Hay, S. I., Holm, M., Hopkins, S., Hsia, Y., Iregbu, K. C., Jacobs, J., Jarovsky, D., Javanmardi, F., Jenney, A. W. J., Khorana, M., Khusuwan, S., Kissoon, N., Kobeissi, E., Kostyanev, T., Krapp, F., Krumkamp, R., Kumar, A., Kyu, H. H., Lim, C., Lim, K., Limmathurotsakul, D., Loftus, M. J., Lunn, M., Ma, J., Manoharan, A., Marks, F., May, J., Mayxay, M., Mturi, N., Munera-Huertas, T., Musicha, P., Musila, L. A., Mussi-Pinhata, M. M., Naidu, R. N., Nakamura, T., Nanavati, R., Nangia, S., Newton, P., Ngoun, C., Novotney, A., Nwakanma, D., Obiero, C. W., Ochoa, T. J., Olivas-Martinez, A., Olliaro, P., Ooko, E., Ortiz-Brizuela, E., Ounchanum, P., Pak, G. D., Paredes, J. L., Peleg, A. Y., Perrone, C., Phe, T., Phommasone, K., Plakkal, N., Ponce-de-Leon, A., Raad, M., Ramdin, T., Rattanavong, S., Riddell, A., Roberts, T., Robotham, J. V., Roca, A., Rosenthal, V. D., Rudd, K. E., Russell, N., Sader, H. S., Saengchan, W., Schnall, J., Scott, J. A. G., Seekaew, S., Sharland, M., Shivamallappa, M., Sifuentes-Osornio, J., Simpson, A. J., Steenkeste, N., Stewardson, A. J., Stoeva, T., Tasak, N., Thaiprakong, A., Thwaites, G., Tigoi, C., Turner, C., Turner, P., van Doorn, H. R., Velaphi, S., Vongpradith, A., Vongsouvath, M., Vu, H., Walsh, T., Walson, J. L., Waner, S., Wangrangsimakul, T., Wannapinij, P., Wozniak, T., Young Sharma, T. E. M. W., Yu, K. C., Zheng, P., Sartorius, B., Lopez, A. D., Stergachis, A., Moore, C., Dolecek, C., & Naghavi, M.
Affiliations
  • Kenya Medical Research Institute (KE)
  • Kwame Nkrumah University of Science and Technology (GH)
  • Stanford University (US)
  • University of Oxford (GB)
  • University of Washington (US)
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
2022-02
Volume
399
Issue
10325
Pages
629-655
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4206677002
Cited by
16,316
References
48
Citations by year
2026: 3459 · 2025: 4006 · 2024: 4174 · 2023: 3176 · 2022: 1481
FWCI
181.82
Type
journal article
Language
en
Update notices
erratum (2022-10-01)
Open access
Licence
Locations
  • The Lancet (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, cc-by)
  • Lirias (KU Leuven) (submittedVersion, cc-by)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • Universidad Peruana Cayetano Heredia Institutional Repository (submittedVersion, cc-by-nc-nd)
Funders
  • Bill and Melinda Gates Foundation (OPP1176062)
  • Wellcome Trust (A126042)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
antimicrobial resistance, bacterial infection, global burden of disease, attributable mortality, disability-adjusted life years, antibiotic resistance, infectious disease mortality, counterfactual scenarios, length of hospital stay, health care costs, uncertainty intervals, cross-validation, sub-Saharan Africa, Australasia, Western Sub-Saharan Africa
MeSH terms
Global Burden of Disease, Anti-Bacterial Agents, Bacterial Infections, Humans, Global Health, Models, Statistical, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(21)02724-0
The paper
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Kashef Hamadani, B. H., Kumaran, E. A. P., McManigal, B., . . . Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. https://doi.org/10.1016/s0140-6736(21)02724-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.